{"gene":"CX3CR1","run_date":"2026-04-28T17:28:53","timeline":{"discoveries":[{"year":2022,"finding":"Cryo-EM structures of CX3CR1-Gi1 complexes in ligand-free and CX3CL1-bound states revealed the structural basis for CX3CL1 recognition, identified key residues governing ligand binding shared with US28, and showed that three cholesterol molecules stabilize conformation and are essential for signaling transduction — with notably smaller helix VI conformational change upon activation compared to other class A GPCR-Gi complexes.","method":"Cryo-electron microscopy at 2.8 Å and 3.4 Å resolution, combined with functional binding/signaling assays and mutagenesis","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 1 — high-resolution cryo-EM structures with functional validation and mutagenesis in a single study","pmids":["35767622"],"is_preprint":false},{"year":2005,"finding":"CX3CR1 is required for lamina propria dendritic cells to form transepithelial dendrites that sample luminal antigens, and controls clearance of entero-invasive pathogens; CX3CR1-deficient mice fail to form these dendrites.","method":"CX3CR1-knockout mice, intravital imaging, bacterial challenge models","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 2 — clean KO with specific cellular and functional phenotype, highly cited foundational study","pmids":["15653504"],"is_preprint":false},{"year":2008,"finding":"CX3CR1 provides an essential survival signal to Gr1low/non-classical monocytes; absence of CX3CR1 or CX3CL1 reduces Gr1low blood monocyte levels, and this is rescued by a Bcl2 transgene. CX3CL1 directly rescues cultured human monocytes from induced cell death, and enforced monocyte/foam cell survival restores atherogenesis in CX3CR1-deficient mice.","method":"CX3CR1/CX3CL1 knockout mice, Bcl2 transgene rescue, in vitro cell death assay with human monocytes, bone marrow transplantation chimeras, atherosclerosis model","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods including genetic rescue and in vitro assay; replicated across conditions","pmids":["18971423"],"is_preprint":false},{"year":2000,"finding":"CX3CR1 is expressed on hippocampal neurons (not only microglia); fractalkine activation of neuronal CX3CR1 induces PI3K/Akt activation and NF-κB nuclear translocation, and protects neurons from gp120-induced neurotoxicity in a PI3K/Akt-dependent manner.","method":"Immunofluorescence, receptor binding, PI3K inhibitors, Akt activator, anti-CX3CR1 antibody blockade in primary hippocampal neuron cultures","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro mechanistic dissection with multiple inhibitors and antibody blockade; foundational paper with >300 citations","pmids":["10869418"],"is_preprint":false},{"year":2011,"finding":"CX3CR1 deficiency in mice impairs hippocampal long-term potentiation (LTP) and causes contextual fear conditioning and Morris water maze deficits; the cognitive and LTP deficits are reversed by IL-1β receptor antagonist infusion, placing CX3CR1 upstream of IL-1β-mediated suppression of synaptic plasticity.","method":"CX3CR1-/- mice, fear conditioning, Morris water maze, LTP electrophysiology, IL-1β receptor antagonist rescue","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — multiple behavioral and electrophysiological readouts with pharmacological rescue defining mechanism","pmids":["22072675"],"is_preprint":false},{"year":2010,"finding":"CX3CR1 limits liver fibrosis by controlling differentiation and survival of intrahepatic monocyte-derived macrophages; CX3CR1 activates anti-apoptotic Bcl2 expression in hepatic monocytes, and its absence causes monocytes to preferentially differentiate into pro-inflammatory TNF/iNOS-producing macrophages, increasing fibrosis.","method":"CX3CR1-/- mice, two liver fibrosis models (CCl4, bile duct ligation), bone marrow transplantation chimeras, Bcl2 expression analysis","journal":"Hepatology (Baltimore, Md.)","confidence":"High","confidence_rationale":"Tier 2 — multiple disease models, chimera experiments establishing cell-autonomous mechanism, multiple orthogonal readouts","pmids":["21038415"],"is_preprint":false},{"year":2013,"finding":"CX3CR1 is expressed on pancreatic islet β cells; its activation by fractalkine increases intracellular Ca2+ and potentiates glucose- and GLP1-stimulated insulin secretion. CX3CR1 KO mice have defective insulin secretion, and FKN treatment upregulates genes required for the differentiated β cell state.","method":"CX3CR1 KO mice, isolated islet functional assays, in vivo glucose tolerance tests, intracellular Ca2+ imaging, gene expression analysis","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro reconstitution with isolated islets, Ca2+ signaling assay, KO phenotype, both mouse and human islets tested","pmids":["23582329"],"is_preprint":false},{"year":2017,"finding":"Tau protein directly binds CX3CR1 (demonstrated by affinity chromatography and competition with CX3CL1), triggering its internalization by microglia; S396 phosphorylation of Tau decreases its binding affinity to CX3CR1, impairing microglial phagocytosis.","method":"Affinity chromatography, Tau-CX3CL1 competition assay, Cy5-Tau uptake in primary microglia cultures and stereotaxic injection into CX3CR1-/- mice","journal":"Molecular neurodegeneration","confidence":"High","confidence_rationale":"Tier 1–2 — direct binding assay with competition, combined with in vivo KO experiment and in vitro functional readout","pmids":["28810892"],"is_preprint":false},{"year":2007,"finding":"Fractalkine (CX3CL1) upregulates ICAM-1 expression in endothelial cells through CX3CR1 (expressed on endothelial cells) via activation of the Jak2/Stat5 signaling pathway, promoting neutrophil adhesion.","method":"RT-PCR, Western blot, siRNA knockdown of CX3CR1 and Stat5, confocal microscopy, neutrophil adhesion assay, mouse heart perfusion model","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 — siRNA knockdown with pathway dissection, multiple cell types and in vivo confirmation","pmids":["17885215"],"is_preprint":false},{"year":2014,"finding":"CX3CR1+ monocytes infiltrate the sciatic nerve in response to vincristine treatment via CX3CL1 signaling; these monocytes produce reactive oxygen species that activate TRPA1 in sensory neurons to evoke neuropathic pain. CX3CR1-deficient mice show delayed allodynia.","method":"CX3CR1-/- mice, monocyte transfer, ROS measurement, TRPA1 pharmacology, allodynia assay","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — KO mice combined with mechanistic dissection of ROS/TRPA1 pathway and cell-transfer experiments","pmids":["24743146"],"is_preprint":false},{"year":2017,"finding":"Female mice maintain hypothalamic CX3CL1-CX3CR1 signaling on high-fat diet while males show reduced expression; female CX3CR1 knockout mice develop male-like hypothalamic microglial accumulation and diet-induced obesity, and increasing brain CX3CL1 in males reduces microglial activation and weight gain.","method":"CX3CR1 KO mice, central pharmacological CX3CL1 administration, virally mediated hypothalamic CX3CL1 overexpression, microglial activation assays, metabolic phenotyping","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — multiple genetic and pharmacological interventions with defined cellular and metabolic phenotypes","pmids":["28223698"],"is_preprint":false},{"year":2017,"finding":"CX3CR1high Ly6Clow peripheral monocytes impair motor learning and learning-related dendritic spine plasticity through TNF-α-dependent mechanisms following peripheral immune activation, without requiring microglial function in the CNS.","method":"Two-photon in vivo imaging of dendritic spines, monocyte depletion, CX3CR1-GFP mice, TNF-α blockade, learning behavioral assays","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 — in vivo imaging combined with cell-specific depletion and cytokine blockade identifying mechanism","pmids":["28504723"],"is_preprint":false},{"year":2002,"finding":"TGF-β1 upregulates CX3CR1 mRNA and protein (125I-fractalkine binding sites) in rat microglia, and blunts fractalkine-stimulated ERK1/2 phosphorylation. The half-life of CX3CR1 mRNA is unaltered, and two Smad binding elements were identified in the rat CX3CR1 promoter, suggesting transcriptional regulation.","method":"Primary rat microglia cultures, radiolabeled fractalkine binding assay, ERK1/2 phosphorylation assay, mRNA stability assay, promoter analysis","journal":"Journal of neuroimmunology","confidence":"Medium","confidence_rationale":"Tier 2 — direct binding and signaling assays; single lab but multiple methods","pmids":["12446007"],"is_preprint":false},{"year":2018,"finding":"Microglial repopulation in the adult retina following ablation is regulated by CX3CL1-CX3CR1 signaling; CX3CR1 deficiency slows repopulation while exogenous CX3CL1 accelerates it. Repopulating microglia under normal CX3CR1 signaling fully restore microglial functions including synaptic maintenance.","method":"In vivo imaging, cell-fate mapping, CX3CR1 KO mice, exogenous CX3CL1 administration, retinal electrophysiology","journal":"Science advances","confidence":"Medium","confidence_rationale":"Tier 2 — genetic and pharmacological manipulation with functional readouts; single study but multiple methods","pmids":["29750189"],"is_preprint":false},{"year":2018,"finding":"Loss of Cx3cr1 in microglia leads to altered cilium protein distribution (Rpgr, Rpgrip1, centrin), failure of cone photoreceptor outer segment elongation, and subsequent cone photoreceptor death during postnatal retinal maturation.","method":"Cx3cr1-/- mice, ERG functional testing, immunofluorescence, bead-chip gene array, quantitative PCR, cilium protein localization","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — KO with specific molecular pathway (cilium gene regulation) and functional phenotype; single study","pmids":["29669747"],"is_preprint":false},{"year":2018,"finding":"CX3CR1 activation by fractalkine promotes hematoma resolution and neurological recovery after germinal matrix hemorrhage via the AMPK/PPARγ signaling pathway, promoting M2 microglial polarization; CRISPR knockout or pharmacological inhibition of CX3CR1 abolished these effects.","method":"Rat GMH model, recombinant fractalkine intranasal administration, CX3CR1 CRISPR KO, selective CX3CR1 inhibitor (AZD8797), liposome-encapsulated AMPK/PPARγ inhibitors, Western blot, ELISA, immunofluorescence","journal":"Stroke","confidence":"Medium","confidence_rationale":"Tier 2 — CRISPR KO and pharmacological inhibition with downstream pathway dissection; single study","pmids":["37465997"],"is_preprint":false},{"year":2018,"finding":"The homozygous CX3CR1-M280 variant impairs CX3CL1-mediated monocyte survival by abolishing AKT and ERK activation downstream of CX3CR1, without affecting receptor surface expression; heterozygous M280 carriers retain survival signaling.","method":"Primary monocytes from WT, heterozygous, and homozygous M280 donors; cell death assays; AKT and ERK phosphorylation; blood monocyte counts","journal":"JCI insight","confidence":"Medium","confidence_rationale":"Tier 2 — human primary cells with direct signaling readouts; single study with multiple assays","pmids":["29415879"],"is_preprint":false},{"year":2019,"finding":"CX3CL1-CX3CR1 interaction between mesothelial cells and macrophages promotes TGFβ-driven peritoneal fibrosis; TGFβ upregulates CX3CR1 on monocytic cells (forming a positive feedback loop), and CX3CR1-expressing macrophages promote mesothelial CX3CL1 and TGFβ expression via direct contact.","method":"CX3CR1 KO mice, peritoneal dialysis model, in vitro macrophage-mesothelial co-culture, TGFβ stimulation assays","journal":"Kidney international","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo KO with in vitro mechanistic follow-up; single lab","pmids":["30948201"],"is_preprint":false},{"year":2012,"finding":"Fractalkine signals through CX3CR1 to activate JAK/STAT pathway in cerulein-stimulated pancreatic AR42J cells; blocking FKN with siRNA or inhibiting JAK with AG490 reduces TNF-α expression in a severe acute pancreatitis rat model.","method":"siRNA knockdown, AG490 JAK inhibitor, Western blot, RT-PCR, immunofluorescence, in vivo SAP rat model","journal":"Inflammation","confidence":"Medium","confidence_rationale":"Tier 2 — siRNA knockdown with pharmacological inhibition; single lab, multiple methods","pmids":["22213034"],"is_preprint":false},{"year":2019,"finding":"CX3CR1 inhibition blocks migration of tendon-resident CX3CR1+/CX3CL1+ 'tenophages' in 3D tendon constructs in vitro, indicating that CX3CR1 mediates these cells' migratory behavior.","method":"3D tendon-like construct model, CX3CR1 inhibition, Cx3cr1-reporter transgenic mice, immunofluorescence","journal":"Disease models & mechanisms","confidence":"Low","confidence_rationale":"Tier 3 — single inhibitor experiment in vitro, limited mechanistic follow-up","pmids":["31744815"],"is_preprint":false},{"year":2003,"finding":"The human CX3CR1 gene is organized with three promoters transcribing three separate exons spliced to a fourth exon containing the coding region; several positive and negative regulatory elements were identified by luciferase reporter assays. Mouse CX3CR1 has a different promoter organization. CX3CR1 and CCR8 arose from duplication of an ancestral gene.","method":"Genomic sequencing, luciferase reporter assays, SNP analysis, evolutionary comparison","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 — direct promoter functional assay with reporter; characterization of gene regulatory architecture","pmids":["12551893"],"is_preprint":false},{"year":2021,"finding":"CX3CR1 functions as a receptor for respiratory syncytial virus (RSV) on pediatric airway epithelial cells; CX3CR1 is expressed on primary differentiated pediatric lung epithelial cells, RSV preferentially infects CX3CR1-positive cells, and blocking CX3CR1/RSV interaction significantly decreases viral load.","method":"In situ hybridization, immunohistochemistry, primary pediatric airway epithelial cell cultures, CX3CR1-blocking antibody, viral load assay","journal":"Pediatric research","confidence":"Medium","confidence_rationale":"Tier 2 — direct blocking experiment in physiologically relevant primary cell model; replicated concept in cotton rat in vivo model (PMID 34037420)","pmids":["31726465","34037420"],"is_preprint":false},{"year":2020,"finding":"IL-15 promotes the phenotype, survival (via STAT5 and Bcl-2), and proliferation (via STAT5 and mTORC1) of CX3CR1+CD57+CD8+ T cells in vitro, whereas TCR stimulation leads to their death, identifying the cytokine signaling pathway maintaining this subset.","method":"In vitro IL-15 stimulation, STAT5 and Bcl-2 inhibitors, mTORC1 inhibitor, flow cytometry, proliferation and survival assays","journal":"JCI insight","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological pathway dissection with multiple inhibitors; single lab","pmids":["32369455"],"is_preprint":false},{"year":2017,"finding":"CX3CR1 regulates osteoarthritic chondrocyte proliferation and apoptosis through the Wnt/β-catenin signaling pathway; siCX3CR1 transfection increased nuclear β-catenin, Cyclin D1, and MMP-13, and these effects were abolished by the Wnt inhibitor XAV-939.","method":"siRNA knockdown in OA chondrocytes, Wnt inhibitor XAV-939, Western blot, qRT-PCR, MTT assay, flow cytometry","journal":"Biomedicine & pharmacotherapy","confidence":"Low","confidence_rationale":"Tier 3 — siRNA and inhibitor in cell culture; single lab, limited in vivo validation","pmids":["29217163"],"is_preprint":false},{"year":2022,"finding":"In arthritis, CX3CR1 deletion reduces acute nociception and DRG non-classical monocyte numbers; in vitro, CGRP liberates CX3CL1 from endothelium and FKN via CX3CR1 activates intracellular kinases in bone marrow-derived macrophages, polarizing them toward M1-like phenotype and promoting IL-6 release.","method":"CX3CR1 KO mice, K/BxN serum transfer arthritis model, DRG macrophage phenotyping, in vitro CGRP/FKN signaling assay in BMDM, kinase activation assays","journal":"Brain, behavior, and immunity","confidence":"Medium","confidence_rationale":"Tier 2 — KO mice with in vitro pathway dissection; single study","pmids":["36115544"],"is_preprint":false}],"current_model":"CX3CR1 is a Gi-coupled GPCR (whose cryo-EM structure reveals cholesterol-dependent activation) whose sole ligand CX3CL1/fractalkine mediates: (1) dendritic cell transepithelial sampling in the gut; (2) AKT/ERK-dependent survival signaling in monocytes, macrophages, and foam cells via Bcl-2 upregulation; (3) neuroprotection through PI3K/Akt and NF-κB in neurons; (4) modulation of microglial activation to regulate synaptic plasticity, LTP, and adult neurogenesis through IL-1β suppression; (5) ICAM-1 upregulation in endothelial cells via Jak2/Stat5; (6) β-cell Ca2+ signaling to potentiate insulin secretion; (7) microglial phagocytic clearance of extracellular Tau; and (8) RSV entry into airway epithelial cells."},"narrative":{"teleology":[{"year":2000,"claim":"Establishing that CX3CR1 is expressed on neurons and directly mediates neuroprotection answered whether fractalkine signaling in the CNS acts only through microglia or also through neuron-autonomous mechanisms.","evidence":"Primary hippocampal neuron cultures with PI3K inhibitors, Akt activators, and anti-CX3CR1 antibody blockade","pmids":["10869418"],"confidence":"High","gaps":["Downstream transcriptional targets of neuronal CX3CR1-NF-κB signaling uncharacterized","In vivo relevance of neuron-autonomous CX3CR1 signaling not directly tested"]},{"year":2003,"claim":"Characterization of the human CX3CR1 promoter architecture — three promoters driving distinct first exons — revealed how tissue- and context-specific transcription of CX3CR1 is organized and showed evolutionary divergence from the mouse gene.","evidence":"Luciferase reporter assays of promoter fragments, genomic sequencing, evolutionary comparison with CCR8","pmids":["12551893"],"confidence":"Medium","gaps":["Cell-type-specific promoter usage in vivo not mapped","Transcription factor occupancy at identified elements not validated by ChIP"]},{"year":2005,"claim":"Demonstrating that CX3CR1 is required for transepithelial dendrite formation by lamina propria dendritic cells established its non-redundant role in intestinal immune surveillance and pathogen clearance.","evidence":"CX3CR1-knockout mice with intravital imaging and entero-invasive bacterial challenge","pmids":["15653504"],"confidence":"High","gaps":["Downstream signaling pathway linking CX3CR1 to dendrite extension in DCs not defined","Contribution of membrane-bound vs. soluble CX3CL1 not resolved"]},{"year":2007,"claim":"Identification of JAK2/STAT5-dependent ICAM-1 upregulation in endothelial cells revealed that CX3CR1 couples to JAK/STAT in addition to canonical Gi pathways, explaining how fractalkine promotes leukocyte adhesion.","evidence":"siRNA knockdown of CX3CR1 and STAT5 in endothelial cells with neutrophil adhesion assay and mouse heart perfusion","pmids":["17885215"],"confidence":"High","gaps":["How CX3CR1-Gi coupling activates JAK2 is mechanistically unresolved","Relative contribution of endothelial vs. leukocyte CX3CR1 in vivo not separated"]},{"year":2008,"claim":"Genetic rescue with a Bcl-2 transgene proved that CX3CR1's principal role in non-classical monocyte homeostasis is anti-apoptotic survival signaling, linking receptor loss to monocytopenia and reduced atherosclerosis.","evidence":"CX3CR1/CX3CL1 KO mice, Bcl-2 transgene rescue, bone marrow chimeras, human monocyte cell death assay","pmids":["18971423"],"confidence":"High","gaps":["Whether AKT or ERK is the dominant pathway upstream of Bcl-2 in vivo not resolved","Kinetics of monocyte death after CX3CL1 withdrawal not defined"]},{"year":2010,"claim":"Extending the survival-signaling model to hepatic macrophages showed that CX3CR1 prevents pro-inflammatory macrophage polarization and liver fibrosis, establishing CX3CR1 as a rheostat between macrophage survival and inflammatory differentiation.","evidence":"CX3CR1-KO mice in CCl4 and bile duct ligation fibrosis models with bone marrow chimeras and Bcl-2 expression analysis","pmids":["21038415"],"confidence":"High","gaps":["Whether TNF/iNOS skewing upon CX3CR1 loss is cell-intrinsic or secondary to reduced Bcl-2 not fully distinguished"]},{"year":2011,"claim":"Pharmacological rescue of hippocampal LTP and cognitive deficits in CX3CR1-KO mice by IL-1β receptor antagonism placed CX3CR1 as a microglial brake on IL-1β release that is required for normal synaptic plasticity.","evidence":"CX3CR1-KO mice, fear conditioning, Morris water maze, LTP recording, IL-1RA intracerebroventricular infusion","pmids":["22072675"],"confidence":"High","gaps":["Molecular mechanism by which CX3CR1 suppresses IL-1β transcription or processing in microglia not identified","Contribution of neuronal vs. microglial CX3CR1 not separated in this model"]},{"year":2013,"claim":"Discovery that CX3CR1 on pancreatic β cells mobilizes intracellular Ca²⁺ to potentiate insulin secretion expanded CX3CR1 biology beyond immune cells to metabolic regulation.","evidence":"CX3CR1-KO mice, isolated islet Ca²⁺ imaging, glucose tolerance tests, gene expression profiling in mouse and human islets","pmids":["23582329"],"confidence":"High","gaps":["G-protein coupling mediating Ca²⁺ release in β cells not defined (Gi typically inhibits Ca²⁺)","Relative contribution of β-cell CX3CR1 vs. islet macrophage CX3CR1 not fully separated"]},{"year":2014,"claim":"Identification of CX3CR1-dependent monocyte infiltration and ROS-TRPA1 activation in chemotherapy-induced neuropathic pain revealed how peripheral CX3CL1–CX3CR1 signaling translates immune recruitment into sensory neuron sensitization.","evidence":"CX3CR1-KO mice, monocyte adoptive transfer, ROS measurement, TRPA1 antagonist, vincristine allodynia model","pmids":["24743146"],"confidence":"High","gaps":["Source of CX3CL1 in the injured nerve not identified","Whether CX3CR1 signaling in monocytes directly controls ROS production or acts indirectly not resolved"]},{"year":2017,"claim":"Direct binding of extracellular Tau to CX3CR1, with competition against CX3CL1, identified CX3CR1 as a microglial receptor for Tau clearance and showed that S396 phosphorylation impairs this interaction — providing a mechanism linking Tau pathology to deficient phagocytic clearance.","evidence":"Affinity chromatography, Tau-CX3CL1 competition, Cy5-Tau uptake in primary microglia and CX3CR1-KO mouse brain","pmids":["28810892"],"confidence":"High","gaps":["Structural basis of Tau-CX3CR1 interaction unknown","Whether Tau binding activates or inhibits CX3CR1 signaling not determined"]},{"year":2017,"claim":"Sex-dimorphic regulation of hypothalamic CX3CL1–CX3CR1 explained why female mice resist diet-induced obesity: CX3CR1 restrains hypothalamic microglial activation and metabolic inflammation in a sex-dependent manner.","evidence":"CX3CR1-KO mice, central CX3CL1 pharmacological and viral overexpression, microglial activation assays, metabolic phenotyping","pmids":["28223698"],"confidence":"High","gaps":["Hormonal regulation of CX3CL1/CX3CR1 expression not mechanistically defined","Downstream microglial effectors linking CX3CR1 to weight regulation not identified"]},{"year":2018,"claim":"Demonstrating that CX3CR1 loss disrupts cilium protein localization and cone photoreceptor maturation revealed a non-canonical developmental role for microglial CX3CR1 signaling in retinal cell differentiation.","evidence":"CX3CR1-KO mice, ERG, immunofluorescence for Rpgr/Rpgrip1/centrin, gene expression profiling","pmids":["29669747"],"confidence":"Medium","gaps":["Whether microglia directly regulate cilium gene expression or act via a secreted factor is unknown","Single-study finding; independent replication needed"]},{"year":2018,"claim":"The homozygous CX3CR1-M280 human variant abolished AKT and ERK phosphorylation without affecting surface expression, confirming that the survival-signaling defect is due to impaired coupling rather than trafficking and validating the mouse KO findings in human primary cells.","evidence":"Primary monocytes from WT, heterozygous, and homozygous M280 donors with phospho-AKT/ERK assays and cell death measurement","pmids":["29415879"],"confidence":"Medium","gaps":["Structural basis of M280-induced signaling defect unknown","Clinical consequences of homozygous M280 on monocyte counts in larger cohorts not established"]},{"year":2021,"claim":"Identification of CX3CR1 as an entry receptor for RSV on airway epithelial cells extended CX3CR1 function beyond chemokine signaling to viral pathogenesis, demonstrating that blocking the CX3CR1–RSV interaction reduces viral load.","evidence":"Primary differentiated pediatric airway epithelial cells, CX3CR1-blocking antibody, in vivo cotton rat model","pmids":["31726465","34037420"],"confidence":"Medium","gaps":["Molecular details of RSV G protein–CX3CR1 binding interface not structurally defined","Whether CX3CR1 mediates viral entry or post-binding steps not separated"]},{"year":2022,"claim":"High-resolution cryo-EM structures of apo and CX3CL1-bound CX3CR1–Gi1 complexes revealed an atypically small helix VI movement upon activation and identified three structural cholesterol molecules essential for signaling, providing the first atomic-level framework for CX3CR1 pharmacology.","evidence":"Cryo-EM at 2.8 Å and 3.4 Å resolution with mutagenesis and functional signaling assays","pmids":["35767622"],"confidence":"High","gaps":["How cholesterol dependence relates to lipid raft requirement in cell-type-specific signaling not tested","Structural basis for Tau binding at CX3CR1 not addressed"]},{"year":null,"claim":"Key unresolved questions include: (1) how CX3CR1-Gi coupling activates JAK/STAT and Ca²⁺ mobilization pathways that are atypical for Gi-linked receptors; (2) whether Tau and CX3CL1 compete at overlapping or distinct CX3CR1 binding sites; and (3) how tissue-specific CX3CR1 promoter usage controls its diverse cell-type expression pattern in vivo.","evidence":"","pmids":[],"confidence":"Low","gaps":["No reconstituted system testing CX3CR1 coupling to JAK/STAT independent of Gi","No co-crystal or cryo-EM structure of Tau–CX3CR1","No in vivo promoter-usage map across cell types"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,3,6,7,21]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[4,5,10]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,3,6,7,8,21]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,3,6,8,16]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[1,2,5,9,24]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[2,5,16]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[3,4,9]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[7,21]}],"complexes":["CX3CR1-Gi1 complex"],"partners":["CX3CL1","GNAI1","MAPT","BCL2","STAT5A","JAK2","AKT1"],"other_free_text":[]},"mechanistic_narrative":"CX3CR1 is a Gi-coupled chemokine receptor for fractalkine (CX3CL1) that transduces survival, migration, and activation signals across diverse cell types including monocytes, microglia, neurons, endothelial cells, and pancreatic β cells. In monocytes and macrophages, CX3CR1 engages AKT/ERK signaling to upregulate Bcl-2 and promote cell survival, thereby controlling non-classical monocyte homeostasis, atherosclerotic foam cell persistence, and hepatic macrophage differentiation [PMID:18971423, PMID:29415879, PMID:21038415]. In the central nervous system, CX3CR1 on microglia restrains IL-1β production to maintain hippocampal LTP and cognitive function, while neuronal CX3CR1 activates PI3K/Akt–NF-κB neuroprotective signaling; in the retina it governs microglial repopulation and cone photoreceptor maturation [PMID:22072675, PMID:10869418, PMID:29669747]. CX3CR1 also serves non-canonical roles as a receptor for extracellular Tau on microglia (mediating phagocytic clearance inhibited by Tau phosphorylation at S396), as an entry receptor for respiratory syncytial virus on airway epithelial cells, and as a potentiator of glucose-stimulated insulin secretion in pancreatic β cells through intracellular Ca²⁺ mobilization [PMID:28810892, PMID:31726465, PMID:23582329]."},"prefetch_data":{"uniprot":{"accession":"P49238","full_name":"CX3C chemokine receptor 1","aliases":["Beta chemokine receptor-like 1","CMK-BRL-1","CMK-BRL1","Fractalkine receptor","G-protein coupled receptor 13","V28"],"length_aa":355,"mass_kda":40.4,"function":"Receptor for the C-X3-C chemokine fractalkine (CX3CL1) present on many early leukocyte cells; CX3CR1-CX3CL1 signaling exerts distinct functions in different tissue compartments, such as immune response, inflammation, cell adhesion and chemotaxis (PubMed:12055230, PubMed:23125415, PubMed:9390561, PubMed:9782118). CX3CR1-CX3CL1 signaling mediates cell migratory functions (By similarity). Responsible for the recruitment of natural killer (NK) cells to inflamed tissues (By similarity). Acts as a regulator of inflammation process leading to atherogenesis by mediating macrophage and monocyte recruitment to inflamed atherosclerotic plaques, promoting cell survival (By similarity). Involved in airway inflammation by promoting interleukin 2-producing T helper (Th2) cell survival in inflamed lung (By similarity). Involved in the migration of circulating monocytes to non-inflamed tissues, where they differentiate into macrophages and dendritic cells (By similarity). Acts as a negative regulator of angiogenesis, probably by promoting macrophage chemotaxis (PubMed:14581400, PubMed:18971423). Plays a key role in brain microglia by regulating inflammatory response in the central nervous system (CNS) and regulating synapse maturation (By similarity). Required to restrain the microglial inflammatory response in the CNS and the resulting parenchymal damage in response to pathological stimuli (By similarity). Involved in brain development by participating in synaptic pruning, a natural process during which brain microglia eliminates extra synapses during postnatal development (By similarity). Synaptic pruning by microglia is required to promote the maturation of circuit connectivity during brain development (By similarity). Acts as an important regulator of the gut microbiota by controlling immunity to intestinal bacteria and fungi (By similarity). Expressed in lamina propria dendritic cells in the small intestine, which form transepithelial dendrites capable of taking up bacteria in order to provide defense against pathogenic bacteria (By similarity). Required to initiate innate and adaptive immune responses against dissemination of commensal fungi (mycobiota) component of the gut: expressed in mononuclear phagocytes (MNPs) and acts by promoting induction of antifungal IgG antibodies response to confer protection against disseminated C.albicans or C.auris infection (PubMed:29326275). Also acts as a receptor for C-C motif chemokine CCL26, inducing cell chemotaxis (PubMed:20974991) (Microbial infection) Acts as a coreceptor with CD4 for HIV-1 virus envelope protein (Microbial infection) Acts as a coreceptor with CD4 for HIV-1 virus envelope protein (PubMed:14607932). May have more potent HIV-1 coreceptothr activity than isoform 1 (PubMed:14607932) (Microbial infection) Acts as a coreceptor with CD4 for HIV-1 virus envelope protein (PubMed:14607932). May have more potent HIV-1 coreceptor activity than isoform 1 (PubMed:14607932)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P49238/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CX3CR1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CX3CR1","total_profiled":1310},"omim":[{"mim_id":"621526","title":"GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE-LIKE PROTEIN; QPCTL","url":"https://www.omim.org/entry/621526"},{"mim_id":"621311","title":"DEVELOPMENTAL DYSPLASIA OF THE HIP 4; DDH4","url":"https://www.omim.org/entry/621311"},{"mim_id":"615612","title":"DEVELOPMENTAL DYSPLASIA OF THE HIP 2; DDH2","url":"https://www.omim.org/entry/615612"},{"mim_id":"613784","title":"MACULAR DEGENERATION, AGE-RELATED, 12; ARMD12","url":"https://www.omim.org/entry/613784"},{"mim_id":"609423","title":"HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO","url":"https://www.omim.org/entry/609423"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":33.1}],"url":"https://www.proteinatlas.org/search/CX3CR1"},"hgnc":{"alias_symbol":["CMKDR1","V28","CCRL1"],"prev_symbol":["GPR13","CMKBRL1"]},"alphafold":{"accession":"P49238","domains":[{"cath_id":"1.20.1070.10","chopping":"27-312","consensus_level":"high","plddt":87.0212,"start":27,"end":312}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P49238","model_url":"https://alphafold.ebi.ac.uk/files/AF-P49238-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P49238-F1-predicted_aligned_error_v6.png","plddt_mean":80.5},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CX3CR1","jax_strain_url":"https://www.jax.org/strain/search?query=CX3CR1"},"sequence":{"accession":"P49238","fasta_url":"https://rest.uniprot.org/uniprotkb/P49238.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P49238/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P49238"}},"corpus_meta":[{"pmid":"15653504","id":"PMC_15653504","title":"CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance.","date":"2005","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/15653504","citation_count":1243,"is_preprint":false},{"pmid":"22072675","id":"PMC_22072675","title":"CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity.","date":"2011","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22072675","citation_count":514,"is_preprint":false},{"pmid":"18971423","id":"PMC_18971423","title":"CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival.","date":"2008","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/18971423","citation_count":393,"is_preprint":false},{"pmid":"10869418","id":"PMC_10869418","title":"Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival.","date":"2000","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10869418","citation_count":321,"is_preprint":false},{"pmid":"24352739","id":"PMC_24352739","title":"Neuron-glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stage.","date":"2013","source":"Open biology","url":"https://pubmed.ncbi.nlm.nih.gov/24352739","citation_count":275,"is_preprint":false},{"pmid":"26404698","id":"PMC_26404698","title":"Functional classification of memory CD8(+) T cells by CX3CR1 expression.","date":"2015","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26404698","citation_count":234,"is_preprint":false},{"pmid":"24813163","id":"PMC_24813163","title":"The atypical chemokine receptor CCRL1 shapes functional CCL21 gradients in lymph nodes.","date":"2014","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24813163","citation_count":231,"is_preprint":false},{"pmid":"21038415","id":"PMC_21038415","title":"The fractalkine receptor CX₃CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes.","date":"2010","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/21038415","citation_count":218,"is_preprint":false},{"pmid":"29361745","id":"PMC_29361745","title":"Microglia and Aging: The Role of the TREM2-DAP12 and CX3CL1-CX3CR1 Axes.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29361745","citation_count":216,"is_preprint":false},{"pmid":"33065974","id":"PMC_33065974","title":"The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/33065974","citation_count":202,"is_preprint":false},{"pmid":"25152714","id":"PMC_25152714","title":"Modulating neurotoxicity through CX3CL1/CX3CR1 signaling.","date":"2014","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25152714","citation_count":186,"is_preprint":false},{"pmid":"28810892","id":"PMC_28810892","title":"Absence of CX3CR1 impairs the internalization of Tau by microglia.","date":"2017","source":"Molecular neurodegeneration","url":"https://pubmed.ncbi.nlm.nih.gov/28810892","citation_count":178,"is_preprint":false},{"pmid":"30097293","id":"PMC_30097293","title":"LAG3+ Regulatory T Cells Restrain Interleukin-23-Producing CX3CR1+ Gut-Resident Macrophages during Group 3 Innate Lymphoid Cell-Driven Colitis.","date":"2018","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/30097293","citation_count":168,"is_preprint":false},{"pmid":"25987130","id":"PMC_25987130","title":"Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/25987130","citation_count":159,"is_preprint":false},{"pmid":"20554025","id":"PMC_20554025","title":"Tickets to the brain: role of CCR2 and CX3CR1 in myeloid cell entry in the CNS.","date":"2010","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/20554025","citation_count":147,"is_preprint":false},{"pmid":"24743146","id":"PMC_24743146","title":"Monocytes expressing CX3CR1 orchestrate the development of vincristine-induced pain.","date":"2014","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/24743146","citation_count":144,"is_preprint":false},{"pmid":"28223698","id":"PMC_28223698","title":"Sex differences in microglial CX3CR1 signalling determine obesity susceptibility in mice.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28223698","citation_count":142,"is_preprint":false},{"pmid":"34492237","id":"PMC_34492237","title":"CX3CL1/CX3CR1 signaling targets for the treatment of neurodegenerative diseases.","date":"2021","source":"Pharmacology & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/34492237","citation_count":141,"is_preprint":false},{"pmid":"18079406","id":"PMC_18079406","title":"CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden.","date":"2007","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18079406","citation_count":139,"is_preprint":false},{"pmid":"9143311","id":"PMC_9143311","title":"CD4-independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry.","date":"1997","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/9143311","citation_count":129,"is_preprint":false},{"pmid":"23582329","id":"PMC_23582329","title":"The fractalkine/CX3CR1 system regulates β cell function and insulin secretion.","date":"2013","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/23582329","citation_count":122,"is_preprint":false},{"pmid":"28504723","id":"PMC_28504723","title":"CX3CR1+ monocytes modulate learning and learning-dependent dendritic spine remodeling via TNF-α.","date":"2017","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28504723","citation_count":111,"is_preprint":false},{"pmid":"23974513","id":"PMC_23974513","title":"Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway.","date":"2013","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/23974513","citation_count":109,"is_preprint":false},{"pmid":"29750189","id":"PMC_29750189","title":"Repopulating retinal microglia restore endogenous organization and function under CX3CL1-CX3CR1 regulation.","date":"2018","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/29750189","citation_count":107,"is_preprint":false},{"pmid":"18424766","id":"PMC_18424766","title":"Decreased expression of the fractalkine receptor CX3CR1 on circulating monocytes as new feature of sepsis-induced immunosuppression.","date":"2008","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/18424766","citation_count":105,"is_preprint":false},{"pmid":"28125278","id":"PMC_28125278","title":"Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension.","date":"2017","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/28125278","citation_count":97,"is_preprint":false},{"pmid":"20055718","id":"PMC_20055718","title":"Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential.","date":"2010","source":"Expert opinion on therapeutic targets","url":"https://pubmed.ncbi.nlm.nih.gov/20055718","citation_count":93,"is_preprint":false},{"pmid":"31356156","id":"PMC_31356156","title":"Cx3CR1 Expression Identifies Distinct Macrophage Populations That Contribute Differentially to Inflammation and Repair.","date":"2019","source":"ImmunoHorizons","url":"https://pubmed.ncbi.nlm.nih.gov/31356156","citation_count":91,"is_preprint":false},{"pmid":"29251592","id":"PMC_29251592","title":"The role of microglia and their CX3CR1 signaling in adult neurogenesis in the olfactory bulb.","date":"2017","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/29251592","citation_count":90,"is_preprint":false},{"pmid":"12446007","id":"PMC_12446007","title":"TGF-beta1 upregulates CX3CR1 expression and inhibits fractalkine-stimulated signaling in rat microglia.","date":"2002","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/12446007","citation_count":85,"is_preprint":false},{"pmid":"19936834","id":"PMC_19936834","title":"Expression of fractalkine receptor CX3CR1 on cochlear macrophages influences survival of hair cells following ototoxic injury.","date":"2009","source":"Journal of the Association for Research in Otolaryngology : JARO","url":"https://pubmed.ncbi.nlm.nih.gov/19936834","citation_count":85,"is_preprint":false},{"pmid":"31201215","id":"PMC_31201215","title":"Targeting Microglia Using Cx3cr1-Cre Lines: Revisiting the Specificity.","date":"2019","source":"eNeuro","url":"https://pubmed.ncbi.nlm.nih.gov/31201215","citation_count":84,"is_preprint":false},{"pmid":"12110009","id":"PMC_12110009","title":"Expression of the fractalkine receptor (CX3CR1) in human kidney diseases.","date":"2002","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/12110009","citation_count":83,"is_preprint":false},{"pmid":"32755573","id":"PMC_32755573","title":"Lysophosphatidic Acid-Mediated GPR35 Signaling in CX3CR1+ Macrophages Regulates Intestinal Homeostasis.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32755573","citation_count":80,"is_preprint":false},{"pmid":"20630606","id":"PMC_20630606","title":"Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer.","date":"2010","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/20630606","citation_count":79,"is_preprint":false},{"pmid":"30948201","id":"PMC_30948201","title":"CX3CL1-CX3CR1 interaction mediates macrophage-mesothelial cross talk and promotes peritoneal fibrosis.","date":"2019","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/30948201","citation_count":75,"is_preprint":false},{"pmid":"24933434","id":"PMC_24933434","title":"Microglia and their CX3CR1 signaling are involved in hippocampal- but not olfactory bulb-related memory and neurogenesis.","date":"2014","source":"Brain, behavior, and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/24933434","citation_count":73,"is_preprint":false},{"pmid":"14533779","id":"PMC_14533779","title":"CX3CL1 and CX3CR1 expression in human brain tissue: noninflammatory control versus multiple sclerosis.","date":"2003","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/14533779","citation_count":70,"is_preprint":false},{"pmid":"15608300","id":"PMC_15608300","title":"Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis.","date":"2005","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/15608300","citation_count":69,"is_preprint":false},{"pmid":"21466443","id":"PMC_21466443","title":"Fractalkine/CX3CR1 signalling in chronic pain and inflammation.","date":"2011","source":"Current pharmaceutical biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/21466443","citation_count":66,"is_preprint":false},{"pmid":"20511186","id":"PMC_20511186","title":"CX3CR1/CX3CL1 axis negatively controls glioma cell invasion and is modulated by transforming growth factor-β1.","date":"2010","source":"Neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/20511186","citation_count":65,"is_preprint":false},{"pmid":"15944936","id":"PMC_15944936","title":"Detection of CX3CR1 single nucleotide polymorphism and expression on archived eyes with age-related macular degeneration.","date":"2005","source":"Histology and histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/15944936","citation_count":64,"is_preprint":false},{"pmid":"17372897","id":"PMC_17372897","title":"Defective antitumor responses in CX3CR1-deficient mice.","date":"2007","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/17372897","citation_count":64,"is_preprint":false},{"pmid":"19001328","id":"PMC_19001328","title":"Polymorphism in the microglial cell-mobilizing CX3CR1 gene is associated with survival in patients with glioblastoma.","date":"2008","source":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/19001328","citation_count":63,"is_preprint":false},{"pmid":"34163473","id":"PMC_34163473","title":"Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34163473","citation_count":62,"is_preprint":false},{"pmid":"24806473","id":"PMC_24806473","title":"CX3CR1 is a modifying gene of survival and progression in amyotrophic lateral sclerosis.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24806473","citation_count":60,"is_preprint":false},{"pmid":"17885215","id":"PMC_17885215","title":"Fractalkine upregulates intercellular adhesion molecule-1 in endothelial cells through CX3CR1 and the Jak Stat5 pathway.","date":"2007","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/17885215","citation_count":56,"is_preprint":false},{"pmid":"22530606","id":"PMC_22530606","title":"Therapeutic potential of the chemokine-receptor duo fractalkine/CX3CR1: an update.","date":"2012","source":"Expert opinion on therapeutic targets","url":"https://pubmed.ncbi.nlm.nih.gov/22530606","citation_count":55,"is_preprint":false},{"pmid":"26285829","id":"PMC_26285829","title":"CX3CR1 is dysregulated in blood and brain from schizophrenia patients.","date":"2015","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/26285829","citation_count":51,"is_preprint":false},{"pmid":"32369455","id":"PMC_32369455","title":"Inflammescent CX3CR1+CD57+CD8+ T cells are generated and expanded by IL-15.","date":"2020","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/32369455","citation_count":51,"is_preprint":false},{"pmid":"32400390","id":"PMC_32400390","title":"Dissecting the phenotypic and functional heterogeneity of mouse inflammatory osteoclasts by the expression of Cx3cr1.","date":"2020","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/32400390","citation_count":51,"is_preprint":false},{"pmid":"26765996","id":"PMC_26765996","title":"Up-regulated fractalkine (FKN) and its receptor CX3CR1 are involved in fructose-induced neuroinflammation: Suppression by curcumin.","date":"2016","source":"Brain, behavior, and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/26765996","citation_count":51,"is_preprint":false},{"pmid":"30843484","id":"PMC_30843484","title":"Crosstalk between the CX3CL1/CX3CR1 Axis and Inflammatory Signaling Pathways in Tissue Injury.","date":"2019","source":"Current protein & peptide science","url":"https://pubmed.ncbi.nlm.nih.gov/30843484","citation_count":50,"is_preprint":false},{"pmid":"25502213","id":"PMC_25502213","title":"Differential expression of the fractalkine chemokine receptor (CX3CR1) in human monocytes during differentiation.","date":"2014","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25502213","citation_count":50,"is_preprint":false},{"pmid":"21451526","id":"PMC_21451526","title":"Fractalkine and its receptor, CX3CR1, promote hypertensive interstitial fibrosis in the kidney.","date":"2011","source":"Hypertension research : official journal of the Japanese Society of Hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/21451526","citation_count":47,"is_preprint":false},{"pmid":"31726465","id":"PMC_31726465","title":"CX3CR1 as a respiratory syncytial virus receptor in pediatric human lung.","date":"2019","source":"Pediatric research","url":"https://pubmed.ncbi.nlm.nih.gov/31726465","citation_count":46,"is_preprint":false},{"pmid":"29259682","id":"PMC_29259682","title":"Therapeutic intervention of inflammatory/immune diseases by inhibition of the fractalkine (CX3CL1)-CX3CR1 pathway.","date":"2016","source":"Inflammation and regeneration","url":"https://pubmed.ncbi.nlm.nih.gov/29259682","citation_count":46,"is_preprint":false},{"pmid":"35767622","id":"PMC_35767622","title":"Activation of the human chemokine receptor CX3CR1 regulated by cholesterol.","date":"2022","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/35767622","citation_count":45,"is_preprint":false},{"pmid":"12028445","id":"PMC_12028445","title":"Fractalkine expression and the recruitment of CX3CR1+ cells in the prolonged mesangial proliferative glomerulonephritis.","date":"2002","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/12028445","citation_count":44,"is_preprint":false},{"pmid":"29669747","id":"PMC_29669747","title":"The Role of the Microglial Cx3cr1 Pathway in the Postnatal Maturation of Retinal Photoreceptors.","date":"2018","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/29669747","citation_count":44,"is_preprint":false},{"pmid":"29446734","id":"PMC_29446734","title":"CX3CL1/CX3CR1 Axis, as the Therapeutic Potential in Renal Diseases: Friend or Foe?","date":"2017","source":"Current gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/29446734","citation_count":43,"is_preprint":false},{"pmid":"34009468","id":"PMC_34009468","title":"Regulation and function of CX3CR1 and its ligand CX3CL1 in kidney disease.","date":"2021","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/34009468","citation_count":41,"is_preprint":false},{"pmid":"32582197","id":"PMC_32582197","title":"Revising CX3CR1 Expression on Murine Classical and Non-classical Monocytes.","date":"2020","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32582197","citation_count":41,"is_preprint":false},{"pmid":"31744815","id":"PMC_31744815","title":"Tenophages: a novel macrophage-like tendon cell population expressing CX3CL1 and CX3CR1.","date":"2019","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/31744815","citation_count":41,"is_preprint":false},{"pmid":"23232206","id":"PMC_23232206","title":"Ccl2, Cx3cr1 and Ccl2/Cx3cr1 chemokine deficiencies are not sufficient to cause age-related retinal degeneration.","date":"2012","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/23232206","citation_count":41,"is_preprint":false},{"pmid":"23956503","id":"PMC_23956503","title":"Fractalkine (CX3CL1) and its receptor CX3CR1 may contribute to increased angiogenesis in diabetic placenta.","date":"2013","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/23956503","citation_count":41,"is_preprint":false},{"pmid":"15153757","id":"PMC_15153757","title":"Fractalkine and its receptor, CX3CR1, upregulation in streptozotocin-induced diabetic kidneys.","date":"2004","source":"Nephron. Experimental nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/15153757","citation_count":40,"is_preprint":false},{"pmid":"38731899","id":"PMC_38731899","title":"CX3CL1 (Fractalkine)-CX3CR1 Axis in Inflammation-Induced Angiogenesis and Tumorigenesis.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38731899","citation_count":39,"is_preprint":false},{"pmid":"32662924","id":"PMC_32662924","title":"Microglial CX3CR1 production increases in Alzheimer's disease and is regulated by noradrenaline.","date":"2020","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/32662924","citation_count":39,"is_preprint":false},{"pmid":"28450294","id":"PMC_28450294","title":"Gas6 Promotes Inflammatory (CCR2hiCX3CR1lo) Monocyte Recruitment in Venous Thrombosis.","date":"2017","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/28450294","citation_count":38,"is_preprint":false},{"pmid":"32236410","id":"PMC_32236410","title":"Role of CX3CR1 signaling in malignant transformation of gliomas.","date":"2020","source":"Neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/32236410","citation_count":37,"is_preprint":false},{"pmid":"36115544","id":"PMC_36115544","title":"Dorsal root ganglia CX3CR1 expressing monocytes/macrophages contribute to arthritis pain.","date":"2022","source":"Brain, behavior, and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/36115544","citation_count":33,"is_preprint":false},{"pmid":"17082760","id":"PMC_17082760","title":"Association study between the CX3CR1 gene and asthma.","date":"2006","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/17082760","citation_count":33,"is_preprint":false},{"pmid":"36644710","id":"PMC_36644710","title":"Fractalkine/CX3CR1-Dependent Modulation of Synaptic and Network Plasticity in Health and Disease.","date":"2023","source":"Neural plasticity","url":"https://pubmed.ncbi.nlm.nih.gov/36644710","citation_count":32,"is_preprint":false},{"pmid":"30497184","id":"PMC_30497184","title":"MicroRNA-195 protection against focal cerebral ischemia by targeting CX3CR1.","date":"2018","source":"Journal of neurosurgery","url":"https://pubmed.ncbi.nlm.nih.gov/30497184","citation_count":32,"is_preprint":false},{"pmid":"25503251","id":"PMC_25503251","title":"CX3CL1/CX3CR1 and CCL2/CCR2 chemokine/chemokine receptor complex in patients with AMD.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25503251","citation_count":31,"is_preprint":false},{"pmid":"37465997","id":"PMC_37465997","title":"Fractalkine Enhances Hematoma Resolution and Improves Neurological Function via CX3CR1/AMPK/PPARγ Pathway After GMH.","date":"2023","source":"Stroke","url":"https://pubmed.ncbi.nlm.nih.gov/37465997","citation_count":30,"is_preprint":false},{"pmid":"33582183","id":"PMC_33582183","title":"Dynamic role of macrophage CX3CR1 expression in inflammatory bowel disease.","date":"2021","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/33582183","citation_count":30,"is_preprint":false},{"pmid":"25070355","id":"PMC_25070355","title":"Intermediate expression of CCRL1 reveals novel subpopulations of medullary thymic epithelial cells that emerge in the postnatal thymus.","date":"2014","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25070355","citation_count":30,"is_preprint":false},{"pmid":"25482732","id":"PMC_25482732","title":"Overexpression of CX3CR1 is associated with cellular metastasis, proliferation and survival in gastric cancer.","date":"2014","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/25482732","citation_count":30,"is_preprint":false},{"pmid":"20004358","id":"PMC_20004358","title":"Relevance of the CX3CL1/fractalkine-CX3CR1 pathway in vasculitis and vasculopathy.","date":"2010","source":"Translational research : the journal of laboratory and clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20004358","citation_count":29,"is_preprint":false},{"pmid":"26393344","id":"PMC_26393344","title":"Metabolic Effects of CX3CR1 Deficiency in Diet-Induced Obese Mice.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26393344","citation_count":29,"is_preprint":false},{"pmid":"26458944","id":"PMC_26458944","title":"Expression pattern of Ccr2 and Cx3cr1 in inherited retinal degeneration.","date":"2015","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/26458944","citation_count":28,"is_preprint":false},{"pmid":"26449606","id":"PMC_26449606","title":"T Cell CX3CR1 Mediates Excess Atherosclerotic Inflammation in Renal Impairment.","date":"2015","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/26449606","citation_count":28,"is_preprint":false},{"pmid":"21425158","id":"PMC_21425158","title":"Chemokine receptor CX3CR1 promotes dendritic cell development under steady-state conditions.","date":"2011","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/21425158","citation_count":28,"is_preprint":false},{"pmid":"22213034","id":"PMC_22213034","title":"Fractalkine upregulates inflammation through CX3CR1 and the Jak-Stat pathway in severe acute pancreatitis rat model.","date":"2012","source":"Inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/22213034","citation_count":28,"is_preprint":false},{"pmid":"35770395","id":"PMC_35770395","title":"Structure and Function of Ligand CX3CL1 and its Receptor CX3CR1 in Cancer.","date":"2022","source":"Current medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35770395","citation_count":28,"is_preprint":false},{"pmid":"23470165","id":"PMC_23470165","title":"Interaction between CX3CL1 and CX3CR1 regulates vasculitis induced by immune complex deposition.","date":"2013","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/23470165","citation_count":27,"is_preprint":false},{"pmid":"20600902","id":"PMC_20600902","title":"Impact of chemokine receptor CX3CR1 in human renal allograft rejection.","date":"2010","source":"Transplant immunology","url":"https://pubmed.ncbi.nlm.nih.gov/20600902","citation_count":27,"is_preprint":false},{"pmid":"29415879","id":"PMC_29415879","title":"The homozygous CX3CR1-M280 mutation impairs human monocyte survival.","date":"2018","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/29415879","citation_count":26,"is_preprint":false},{"pmid":"31780870","id":"PMC_31780870","title":"Role of CX3CL1/CX3CR1 Signaling Axis Activity in Osteoporosis.","date":"2019","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/31780870","citation_count":26,"is_preprint":false},{"pmid":"25845619","id":"PMC_25845619","title":"Chemokine CX3CL1 and its receptor CX3CR1 are associated with human atherosclerotic lesion volnerability.","date":"2015","source":"Thrombosis research","url":"https://pubmed.ncbi.nlm.nih.gov/25845619","citation_count":26,"is_preprint":false},{"pmid":"29217163","id":"PMC_29217163","title":"CX3CR1 regulates osteoarthrosis chondrocyte proliferation and apoptosis via Wnt/β-catenin signaling.","date":"2017","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/29217163","citation_count":25,"is_preprint":false},{"pmid":"34037420","id":"PMC_34037420","title":"CX3CR1 Is a Receptor for Human Respiratory Syncytial Virus in Cotton Rats.","date":"2021","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/34037420","citation_count":24,"is_preprint":false},{"pmid":"33641164","id":"PMC_33641164","title":"Potential biomarkers reflecting inflammation in patients with severe periodontitis: Fractalkine (CX3CL1) and its receptor (CX3CR1).","date":"2021","source":"Journal of periodontal research","url":"https://pubmed.ncbi.nlm.nih.gov/33641164","citation_count":24,"is_preprint":false},{"pmid":"28978662","id":"PMC_28978662","title":"Fractalkine induces angiogenic potential in CX3CR1-expressing monocytes.","date":"2017","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/28978662","citation_count":23,"is_preprint":false},{"pmid":"37771579","id":"PMC_37771579","title":"The CX3CL1-CX3CR1 chemokine axis can contribute to tumor immune evasion and blockade with a novel CX3CR1 monoclonal antibody enhances response to anti-PD-1 immunotherapy.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37771579","citation_count":23,"is_preprint":false},{"pmid":"34037810","id":"PMC_34037810","title":"CD40 and CD80/86 signaling in cDC1s mediate effective neoantigen vaccination and generation of antigen-specific CX3CR1+ CD8+ T cells.","date":"2021","source":"Cancer immunology, immunotherapy : CII","url":"https://pubmed.ncbi.nlm.nih.gov/34037810","citation_count":23,"is_preprint":false},{"pmid":"24084767","id":"PMC_24084767","title":"Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesis.","date":"2013","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/24084767","citation_count":22,"is_preprint":false},{"pmid":"12551893","id":"PMC_12551893","title":"Genomic organization and evolution of the CX3CR1/CCR8 chemokine receptor locus.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12551893","citation_count":21,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51173,"output_tokens":5894,"usd":0.120965},"stage2":{"model":"claude-opus-4-6","input_tokens":9583,"output_tokens":3921,"usd":0.21891},"total_usd":0.339875,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2022,\n      \"finding\": \"Cryo-EM structures of CX3CR1-Gi1 complexes in ligand-free and CX3CL1-bound states revealed the structural basis for CX3CL1 recognition, identified key residues governing ligand binding shared with US28, and showed that three cholesterol molecules stabilize conformation and are essential for signaling transduction — with notably smaller helix VI conformational change upon activation compared to other class A GPCR-Gi complexes.\",\n      \"method\": \"Cryo-electron microscopy at 2.8 Å and 3.4 Å resolution, combined with functional binding/signaling assays and mutagenesis\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution cryo-EM structures with functional validation and mutagenesis in a single study\",\n      \"pmids\": [\"35767622\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"CX3CR1 is required for lamina propria dendritic cells to form transepithelial dendrites that sample luminal antigens, and controls clearance of entero-invasive pathogens; CX3CR1-deficient mice fail to form these dendrites.\",\n      \"method\": \"CX3CR1-knockout mice, intravital imaging, bacterial challenge models\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with specific cellular and functional phenotype, highly cited foundational study\",\n      \"pmids\": [\"15653504\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"CX3CR1 provides an essential survival signal to Gr1low/non-classical monocytes; absence of CX3CR1 or CX3CL1 reduces Gr1low blood monocyte levels, and this is rescued by a Bcl2 transgene. CX3CL1 directly rescues cultured human monocytes from induced cell death, and enforced monocyte/foam cell survival restores atherogenesis in CX3CR1-deficient mice.\",\n      \"method\": \"CX3CR1/CX3CL1 knockout mice, Bcl2 transgene rescue, in vitro cell death assay with human monocytes, bone marrow transplantation chimeras, atherosclerosis model\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods including genetic rescue and in vitro assay; replicated across conditions\",\n      \"pmids\": [\"18971423\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"CX3CR1 is expressed on hippocampal neurons (not only microglia); fractalkine activation of neuronal CX3CR1 induces PI3K/Akt activation and NF-κB nuclear translocation, and protects neurons from gp120-induced neurotoxicity in a PI3K/Akt-dependent manner.\",\n      \"method\": \"Immunofluorescence, receptor binding, PI3K inhibitors, Akt activator, anti-CX3CR1 antibody blockade in primary hippocampal neuron cultures\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro mechanistic dissection with multiple inhibitors and antibody blockade; foundational paper with >300 citations\",\n      \"pmids\": [\"10869418\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"CX3CR1 deficiency in mice impairs hippocampal long-term potentiation (LTP) and causes contextual fear conditioning and Morris water maze deficits; the cognitive and LTP deficits are reversed by IL-1β receptor antagonist infusion, placing CX3CR1 upstream of IL-1β-mediated suppression of synaptic plasticity.\",\n      \"method\": \"CX3CR1-/- mice, fear conditioning, Morris water maze, LTP electrophysiology, IL-1β receptor antagonist rescue\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple behavioral and electrophysiological readouts with pharmacological rescue defining mechanism\",\n      \"pmids\": [\"22072675\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"CX3CR1 limits liver fibrosis by controlling differentiation and survival of intrahepatic monocyte-derived macrophages; CX3CR1 activates anti-apoptotic Bcl2 expression in hepatic monocytes, and its absence causes monocytes to preferentially differentiate into pro-inflammatory TNF/iNOS-producing macrophages, increasing fibrosis.\",\n      \"method\": \"CX3CR1-/- mice, two liver fibrosis models (CCl4, bile duct ligation), bone marrow transplantation chimeras, Bcl2 expression analysis\",\n      \"journal\": \"Hepatology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple disease models, chimera experiments establishing cell-autonomous mechanism, multiple orthogonal readouts\",\n      \"pmids\": [\"21038415\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CX3CR1 is expressed on pancreatic islet β cells; its activation by fractalkine increases intracellular Ca2+ and potentiates glucose- and GLP1-stimulated insulin secretion. CX3CR1 KO mice have defective insulin secretion, and FKN treatment upregulates genes required for the differentiated β cell state.\",\n      \"method\": \"CX3CR1 KO mice, isolated islet functional assays, in vivo glucose tolerance tests, intracellular Ca2+ imaging, gene expression analysis\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro reconstitution with isolated islets, Ca2+ signaling assay, KO phenotype, both mouse and human islets tested\",\n      \"pmids\": [\"23582329\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Tau protein directly binds CX3CR1 (demonstrated by affinity chromatography and competition with CX3CL1), triggering its internalization by microglia; S396 phosphorylation of Tau decreases its binding affinity to CX3CR1, impairing microglial phagocytosis.\",\n      \"method\": \"Affinity chromatography, Tau-CX3CL1 competition assay, Cy5-Tau uptake in primary microglia cultures and stereotaxic injection into CX3CR1-/- mice\",\n      \"journal\": \"Molecular neurodegeneration\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct binding assay with competition, combined with in vivo KO experiment and in vitro functional readout\",\n      \"pmids\": [\"28810892\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Fractalkine (CX3CL1) upregulates ICAM-1 expression in endothelial cells through CX3CR1 (expressed on endothelial cells) via activation of the Jak2/Stat5 signaling pathway, promoting neutrophil adhesion.\",\n      \"method\": \"RT-PCR, Western blot, siRNA knockdown of CX3CR1 and Stat5, confocal microscopy, neutrophil adhesion assay, mouse heart perfusion model\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — siRNA knockdown with pathway dissection, multiple cell types and in vivo confirmation\",\n      \"pmids\": [\"17885215\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"CX3CR1+ monocytes infiltrate the sciatic nerve in response to vincristine treatment via CX3CL1 signaling; these monocytes produce reactive oxygen species that activate TRPA1 in sensory neurons to evoke neuropathic pain. CX3CR1-deficient mice show delayed allodynia.\",\n      \"method\": \"CX3CR1-/- mice, monocyte transfer, ROS measurement, TRPA1 pharmacology, allodynia assay\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO mice combined with mechanistic dissection of ROS/TRPA1 pathway and cell-transfer experiments\",\n      \"pmids\": [\"24743146\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Female mice maintain hypothalamic CX3CL1-CX3CR1 signaling on high-fat diet while males show reduced expression; female CX3CR1 knockout mice develop male-like hypothalamic microglial accumulation and diet-induced obesity, and increasing brain CX3CL1 in males reduces microglial activation and weight gain.\",\n      \"method\": \"CX3CR1 KO mice, central pharmacological CX3CL1 administration, virally mediated hypothalamic CX3CL1 overexpression, microglial activation assays, metabolic phenotyping\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic and pharmacological interventions with defined cellular and metabolic phenotypes\",\n      \"pmids\": [\"28223698\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"CX3CR1high Ly6Clow peripheral monocytes impair motor learning and learning-related dendritic spine plasticity through TNF-α-dependent mechanisms following peripheral immune activation, without requiring microglial function in the CNS.\",\n      \"method\": \"Two-photon in vivo imaging of dendritic spines, monocyte depletion, CX3CR1-GFP mice, TNF-α blockade, learning behavioral assays\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo imaging combined with cell-specific depletion and cytokine blockade identifying mechanism\",\n      \"pmids\": [\"28504723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"TGF-β1 upregulates CX3CR1 mRNA and protein (125I-fractalkine binding sites) in rat microglia, and blunts fractalkine-stimulated ERK1/2 phosphorylation. The half-life of CX3CR1 mRNA is unaltered, and two Smad binding elements were identified in the rat CX3CR1 promoter, suggesting transcriptional regulation.\",\n      \"method\": \"Primary rat microglia cultures, radiolabeled fractalkine binding assay, ERK1/2 phosphorylation assay, mRNA stability assay, promoter analysis\",\n      \"journal\": \"Journal of neuroimmunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct binding and signaling assays; single lab but multiple methods\",\n      \"pmids\": [\"12446007\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Microglial repopulation in the adult retina following ablation is regulated by CX3CL1-CX3CR1 signaling; CX3CR1 deficiency slows repopulation while exogenous CX3CL1 accelerates it. Repopulating microglia under normal CX3CR1 signaling fully restore microglial functions including synaptic maintenance.\",\n      \"method\": \"In vivo imaging, cell-fate mapping, CX3CR1 KO mice, exogenous CX3CL1 administration, retinal electrophysiology\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic and pharmacological manipulation with functional readouts; single study but multiple methods\",\n      \"pmids\": [\"29750189\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Loss of Cx3cr1 in microglia leads to altered cilium protein distribution (Rpgr, Rpgrip1, centrin), failure of cone photoreceptor outer segment elongation, and subsequent cone photoreceptor death during postnatal retinal maturation.\",\n      \"method\": \"Cx3cr1-/- mice, ERG functional testing, immunofluorescence, bead-chip gene array, quantitative PCR, cilium protein localization\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO with specific molecular pathway (cilium gene regulation) and functional phenotype; single study\",\n      \"pmids\": [\"29669747\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CX3CR1 activation by fractalkine promotes hematoma resolution and neurological recovery after germinal matrix hemorrhage via the AMPK/PPARγ signaling pathway, promoting M2 microglial polarization; CRISPR knockout or pharmacological inhibition of CX3CR1 abolished these effects.\",\n      \"method\": \"Rat GMH model, recombinant fractalkine intranasal administration, CX3CR1 CRISPR KO, selective CX3CR1 inhibitor (AZD8797), liposome-encapsulated AMPK/PPARγ inhibitors, Western blot, ELISA, immunofluorescence\",\n      \"journal\": \"Stroke\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — CRISPR KO and pharmacological inhibition with downstream pathway dissection; single study\",\n      \"pmids\": [\"37465997\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The homozygous CX3CR1-M280 variant impairs CX3CL1-mediated monocyte survival by abolishing AKT and ERK activation downstream of CX3CR1, without affecting receptor surface expression; heterozygous M280 carriers retain survival signaling.\",\n      \"method\": \"Primary monocytes from WT, heterozygous, and homozygous M280 donors; cell death assays; AKT and ERK phosphorylation; blood monocyte counts\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — human primary cells with direct signaling readouts; single study with multiple assays\",\n      \"pmids\": [\"29415879\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CX3CL1-CX3CR1 interaction between mesothelial cells and macrophages promotes TGFβ-driven peritoneal fibrosis; TGFβ upregulates CX3CR1 on monocytic cells (forming a positive feedback loop), and CX3CR1-expressing macrophages promote mesothelial CX3CL1 and TGFβ expression via direct contact.\",\n      \"method\": \"CX3CR1 KO mice, peritoneal dialysis model, in vitro macrophage-mesothelial co-culture, TGFβ stimulation assays\",\n      \"journal\": \"Kidney international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo KO with in vitro mechanistic follow-up; single lab\",\n      \"pmids\": [\"30948201\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Fractalkine signals through CX3CR1 to activate JAK/STAT pathway in cerulein-stimulated pancreatic AR42J cells; blocking FKN with siRNA or inhibiting JAK with AG490 reduces TNF-α expression in a severe acute pancreatitis rat model.\",\n      \"method\": \"siRNA knockdown, AG490 JAK inhibitor, Western blot, RT-PCR, immunofluorescence, in vivo SAP rat model\",\n      \"journal\": \"Inflammation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — siRNA knockdown with pharmacological inhibition; single lab, multiple methods\",\n      \"pmids\": [\"22213034\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CX3CR1 inhibition blocks migration of tendon-resident CX3CR1+/CX3CL1+ 'tenophages' in 3D tendon constructs in vitro, indicating that CX3CR1 mediates these cells' migratory behavior.\",\n      \"method\": \"3D tendon-like construct model, CX3CR1 inhibition, Cx3cr1-reporter transgenic mice, immunofluorescence\",\n      \"journal\": \"Disease models & mechanisms\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single inhibitor experiment in vitro, limited mechanistic follow-up\",\n      \"pmids\": [\"31744815\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The human CX3CR1 gene is organized with three promoters transcribing three separate exons spliced to a fourth exon containing the coding region; several positive and negative regulatory elements were identified by luciferase reporter assays. Mouse CX3CR1 has a different promoter organization. CX3CR1 and CCR8 arose from duplication of an ancestral gene.\",\n      \"method\": \"Genomic sequencing, luciferase reporter assays, SNP analysis, evolutionary comparison\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — direct promoter functional assay with reporter; characterization of gene regulatory architecture\",\n      \"pmids\": [\"12551893\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CX3CR1 functions as a receptor for respiratory syncytial virus (RSV) on pediatric airway epithelial cells; CX3CR1 is expressed on primary differentiated pediatric lung epithelial cells, RSV preferentially infects CX3CR1-positive cells, and blocking CX3CR1/RSV interaction significantly decreases viral load.\",\n      \"method\": \"In situ hybridization, immunohistochemistry, primary pediatric airway epithelial cell cultures, CX3CR1-blocking antibody, viral load assay\",\n      \"journal\": \"Pediatric research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct blocking experiment in physiologically relevant primary cell model; replicated concept in cotton rat in vivo model (PMID 34037420)\",\n      \"pmids\": [\"31726465\", \"34037420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"IL-15 promotes the phenotype, survival (via STAT5 and Bcl-2), and proliferation (via STAT5 and mTORC1) of CX3CR1+CD57+CD8+ T cells in vitro, whereas TCR stimulation leads to their death, identifying the cytokine signaling pathway maintaining this subset.\",\n      \"method\": \"In vitro IL-15 stimulation, STAT5 and Bcl-2 inhibitors, mTORC1 inhibitor, flow cytometry, proliferation and survival assays\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological pathway dissection with multiple inhibitors; single lab\",\n      \"pmids\": [\"32369455\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"CX3CR1 regulates osteoarthritic chondrocyte proliferation and apoptosis through the Wnt/β-catenin signaling pathway; siCX3CR1 transfection increased nuclear β-catenin, Cyclin D1, and MMP-13, and these effects were abolished by the Wnt inhibitor XAV-939.\",\n      \"method\": \"siRNA knockdown in OA chondrocytes, Wnt inhibitor XAV-939, Western blot, qRT-PCR, MTT assay, flow cytometry\",\n      \"journal\": \"Biomedicine & pharmacotherapy\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — siRNA and inhibitor in cell culture; single lab, limited in vivo validation\",\n      \"pmids\": [\"29217163\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In arthritis, CX3CR1 deletion reduces acute nociception and DRG non-classical monocyte numbers; in vitro, CGRP liberates CX3CL1 from endothelium and FKN via CX3CR1 activates intracellular kinases in bone marrow-derived macrophages, polarizing them toward M1-like phenotype and promoting IL-6 release.\",\n      \"method\": \"CX3CR1 KO mice, K/BxN serum transfer arthritis model, DRG macrophage phenotyping, in vitro CGRP/FKN signaling assay in BMDM, kinase activation assays\",\n      \"journal\": \"Brain, behavior, and immunity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mice with in vitro pathway dissection; single study\",\n      \"pmids\": [\"36115544\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CX3CR1 is a Gi-coupled GPCR (whose cryo-EM structure reveals cholesterol-dependent activation) whose sole ligand CX3CL1/fractalkine mediates: (1) dendritic cell transepithelial sampling in the gut; (2) AKT/ERK-dependent survival signaling in monocytes, macrophages, and foam cells via Bcl-2 upregulation; (3) neuroprotection through PI3K/Akt and NF-κB in neurons; (4) modulation of microglial activation to regulate synaptic plasticity, LTP, and adult neurogenesis through IL-1β suppression; (5) ICAM-1 upregulation in endothelial cells via Jak2/Stat5; (6) β-cell Ca2+ signaling to potentiate insulin secretion; (7) microglial phagocytic clearance of extracellular Tau; and (8) RSV entry into airway epithelial cells.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CX3CR1 is a Gi-coupled chemokine receptor for fractalkine (CX3CL1) that transduces survival, migration, and activation signals across diverse cell types including monocytes, microglia, neurons, endothelial cells, and pancreatic β cells. In monocytes and macrophages, CX3CR1 engages AKT/ERK signaling to upregulate Bcl-2 and promote cell survival, thereby controlling non-classical monocyte homeostasis, atherosclerotic foam cell persistence, and hepatic macrophage differentiation [PMID:18971423, PMID:29415879, PMID:21038415]. In the central nervous system, CX3CR1 on microglia restrains IL-1β production to maintain hippocampal LTP and cognitive function, while neuronal CX3CR1 activates PI3K/Akt–NF-κB neuroprotective signaling; in the retina it governs microglial repopulation and cone photoreceptor maturation [PMID:22072675, PMID:10869418, PMID:29669747]. CX3CR1 also serves non-canonical roles as a receptor for extracellular Tau on microglia (mediating phagocytic clearance inhibited by Tau phosphorylation at S396), as an entry receptor for respiratory syncytial virus on airway epithelial cells, and as a potentiator of glucose-stimulated insulin secretion in pancreatic β cells through intracellular Ca²⁺ mobilization [PMID:28810892, PMID:31726465, PMID:23582329].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Establishing that CX3CR1 is expressed on neurons and directly mediates neuroprotection answered whether fractalkine signaling in the CNS acts only through microglia or also through neuron-autonomous mechanisms.\",\n      \"evidence\": \"Primary hippocampal neuron cultures with PI3K inhibitors, Akt activators, and anti-CX3CR1 antibody blockade\",\n      \"pmids\": [\"10869418\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream transcriptional targets of neuronal CX3CR1-NF-κB signaling uncharacterized\", \"In vivo relevance of neuron-autonomous CX3CR1 signaling not directly tested\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Characterization of the human CX3CR1 promoter architecture — three promoters driving distinct first exons — revealed how tissue- and context-specific transcription of CX3CR1 is organized and showed evolutionary divergence from the mouse gene.\",\n      \"evidence\": \"Luciferase reporter assays of promoter fragments, genomic sequencing, evolutionary comparison with CCR8\",\n      \"pmids\": [\"12551893\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Cell-type-specific promoter usage in vivo not mapped\", \"Transcription factor occupancy at identified elements not validated by ChIP\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrating that CX3CR1 is required for transepithelial dendrite formation by lamina propria dendritic cells established its non-redundant role in intestinal immune surveillance and pathogen clearance.\",\n      \"evidence\": \"CX3CR1-knockout mice with intravital imaging and entero-invasive bacterial challenge\",\n      \"pmids\": [\"15653504\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream signaling pathway linking CX3CR1 to dendrite extension in DCs not defined\", \"Contribution of membrane-bound vs. soluble CX3CL1 not resolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identification of JAK2/STAT5-dependent ICAM-1 upregulation in endothelial cells revealed that CX3CR1 couples to JAK/STAT in addition to canonical Gi pathways, explaining how fractalkine promotes leukocyte adhesion.\",\n      \"evidence\": \"siRNA knockdown of CX3CR1 and STAT5 in endothelial cells with neutrophil adhesion assay and mouse heart perfusion\",\n      \"pmids\": [\"17885215\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How CX3CR1-Gi coupling activates JAK2 is mechanistically unresolved\", \"Relative contribution of endothelial vs. leukocyte CX3CR1 in vivo not separated\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Genetic rescue with a Bcl-2 transgene proved that CX3CR1's principal role in non-classical monocyte homeostasis is anti-apoptotic survival signaling, linking receptor loss to monocytopenia and reduced atherosclerosis.\",\n      \"evidence\": \"CX3CR1/CX3CL1 KO mice, Bcl-2 transgene rescue, bone marrow chimeras, human monocyte cell death assay\",\n      \"pmids\": [\"18971423\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether AKT or ERK is the dominant pathway upstream of Bcl-2 in vivo not resolved\", \"Kinetics of monocyte death after CX3CL1 withdrawal not defined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Extending the survival-signaling model to hepatic macrophages showed that CX3CR1 prevents pro-inflammatory macrophage polarization and liver fibrosis, establishing CX3CR1 as a rheostat between macrophage survival and inflammatory differentiation.\",\n      \"evidence\": \"CX3CR1-KO mice in CCl4 and bile duct ligation fibrosis models with bone marrow chimeras and Bcl-2 expression analysis\",\n      \"pmids\": [\"21038415\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TNF/iNOS skewing upon CX3CR1 loss is cell-intrinsic or secondary to reduced Bcl-2 not fully distinguished\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Pharmacological rescue of hippocampal LTP and cognitive deficits in CX3CR1-KO mice by IL-1β receptor antagonism placed CX3CR1 as a microglial brake on IL-1β release that is required for normal synaptic plasticity.\",\n      \"evidence\": \"CX3CR1-KO mice, fear conditioning, Morris water maze, LTP recording, IL-1RA intracerebroventricular infusion\",\n      \"pmids\": [\"22072675\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism by which CX3CR1 suppresses IL-1β transcription or processing in microglia not identified\", \"Contribution of neuronal vs. microglial CX3CR1 not separated in this model\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Discovery that CX3CR1 on pancreatic β cells mobilizes intracellular Ca²⁺ to potentiate insulin secretion expanded CX3CR1 biology beyond immune cells to metabolic regulation.\",\n      \"evidence\": \"CX3CR1-KO mice, isolated islet Ca²⁺ imaging, glucose tolerance tests, gene expression profiling in mouse and human islets\",\n      \"pmids\": [\"23582329\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"G-protein coupling mediating Ca²⁺ release in β cells not defined (Gi typically inhibits Ca²⁺)\", \"Relative contribution of β-cell CX3CR1 vs. islet macrophage CX3CR1 not fully separated\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identification of CX3CR1-dependent monocyte infiltration and ROS-TRPA1 activation in chemotherapy-induced neuropathic pain revealed how peripheral CX3CL1–CX3CR1 signaling translates immune recruitment into sensory neuron sensitization.\",\n      \"evidence\": \"CX3CR1-KO mice, monocyte adoptive transfer, ROS measurement, TRPA1 antagonist, vincristine allodynia model\",\n      \"pmids\": [\"24743146\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Source of CX3CL1 in the injured nerve not identified\", \"Whether CX3CR1 signaling in monocytes directly controls ROS production or acts indirectly not resolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Direct binding of extracellular Tau to CX3CR1, with competition against CX3CL1, identified CX3CR1 as a microglial receptor for Tau clearance and showed that S396 phosphorylation impairs this interaction — providing a mechanism linking Tau pathology to deficient phagocytic clearance.\",\n      \"evidence\": \"Affinity chromatography, Tau-CX3CL1 competition, Cy5-Tau uptake in primary microglia and CX3CR1-KO mouse brain\",\n      \"pmids\": [\"28810892\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of Tau-CX3CR1 interaction unknown\", \"Whether Tau binding activates or inhibits CX3CR1 signaling not determined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Sex-dimorphic regulation of hypothalamic CX3CL1–CX3CR1 explained why female mice resist diet-induced obesity: CX3CR1 restrains hypothalamic microglial activation and metabolic inflammation in a sex-dependent manner.\",\n      \"evidence\": \"CX3CR1-KO mice, central CX3CL1 pharmacological and viral overexpression, microglial activation assays, metabolic phenotyping\",\n      \"pmids\": [\"28223698\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Hormonal regulation of CX3CL1/CX3CR1 expression not mechanistically defined\", \"Downstream microglial effectors linking CX3CR1 to weight regulation not identified\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Demonstrating that CX3CR1 loss disrupts cilium protein localization and cone photoreceptor maturation revealed a non-canonical developmental role for microglial CX3CR1 signaling in retinal cell differentiation.\",\n      \"evidence\": \"CX3CR1-KO mice, ERG, immunofluorescence for Rpgr/Rpgrip1/centrin, gene expression profiling\",\n      \"pmids\": [\"29669747\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether microglia directly regulate cilium gene expression or act via a secreted factor is unknown\", \"Single-study finding; independent replication needed\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"The homozygous CX3CR1-M280 human variant abolished AKT and ERK phosphorylation without affecting surface expression, confirming that the survival-signaling defect is due to impaired coupling rather than trafficking and validating the mouse KO findings in human primary cells.\",\n      \"evidence\": \"Primary monocytes from WT, heterozygous, and homozygous M280 donors with phospho-AKT/ERK assays and cell death measurement\",\n      \"pmids\": [\"29415879\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of M280-induced signaling defect unknown\", \"Clinical consequences of homozygous M280 on monocyte counts in larger cohorts not established\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identification of CX3CR1 as an entry receptor for RSV on airway epithelial cells extended CX3CR1 function beyond chemokine signaling to viral pathogenesis, demonstrating that blocking the CX3CR1–RSV interaction reduces viral load.\",\n      \"evidence\": \"Primary differentiated pediatric airway epithelial cells, CX3CR1-blocking antibody, in vivo cotton rat model\",\n      \"pmids\": [\"31726465\", \"34037420\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular details of RSV G protein–CX3CR1 binding interface not structurally defined\", \"Whether CX3CR1 mediates viral entry or post-binding steps not separated\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"High-resolution cryo-EM structures of apo and CX3CL1-bound CX3CR1–Gi1 complexes revealed an atypically small helix VI movement upon activation and identified three structural cholesterol molecules essential for signaling, providing the first atomic-level framework for CX3CR1 pharmacology.\",\n      \"evidence\": \"Cryo-EM at 2.8 Å and 3.4 Å resolution with mutagenesis and functional signaling assays\",\n      \"pmids\": [\"35767622\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How cholesterol dependence relates to lipid raft requirement in cell-type-specific signaling not tested\", \"Structural basis for Tau binding at CX3CR1 not addressed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: (1) how CX3CR1-Gi coupling activates JAK/STAT and Ca²⁺ mobilization pathways that are atypical for Gi-linked receptors; (2) whether Tau and CX3CL1 compete at overlapping or distinct CX3CR1 binding sites; and (3) how tissue-specific CX3CR1 promoter usage controls its diverse cell-type expression pattern in vivo.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No reconstituted system testing CX3CR1 coupling to JAK/STAT independent of Gi\", \"No co-crystal or cryo-EM structure of Tau–CX3CR1\", \"No in vivo promoter-usage map across cell types\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 3, 6, 7, 21]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [4, 5, 10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 3, 6, 7, 8, 21]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 3, 6, 8, 16]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [1, 2, 5, 9, 24]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [2, 5, 16]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [3, 4, 9]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [7, 21]}\n    ],\n    \"complexes\": [\n      \"CX3CR1-Gi1 complex\"\n    ],\n    \"partners\": [\n      \"CX3CL1\",\n      \"GNAI1\",\n      \"MAPT\",\n      \"BCL2\",\n      \"STAT5A\",\n      \"JAK2\",\n      \"AKT1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}